Pioneer a gold standard for CGT commercialization
Co-create a commercial toolkit that enables suitable, scalable and sustainable growth
Reuters Events: Cell & Gene Therapy USA 2022 Virtual is the key event for industry trailblazers to discuss pressing topics and navigate testing topics. Join 1500+ CGT frontrunners in pioneering a gold standard precision medicine commercialization and download the brochure today.
This year’s world class speaker line-up includes:
Key themes for 2022 include:
  • Tried and tested case-studies to construct your own infallible commercial strategy: Learn lessons of launches past from industry trailblazers to adapt your own and ensure commercialization success.  
  • Manage unprecedented post-launch demand to ensure patient satisfaction: Analyse nuances in delivery model variations, such as in-house vs CMO’s and allogeneic vs autologous, to ensure your supply chain reflects the bespoke nature of precision medicine and accommodate the ability to adapt to market demand.
  • Innovate value evaluation to consolidate reimbursement strategy: Diversify your skillset, explore the impact patient pools have on value demonstrations and track end-points throughout RWE data collection to validate value claims and support payer assessment.
With over 1500 decision-makers coming from:
…and more!
Please don’t hesitate to reach out with any questions!
Kind regards,
Explore the full agenda and industry-leading speaker line up today

Reuters Events will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy: https://www.thomsonreuters.com/en/privacy-statement.html.

















































Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.